1. Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer
- Author
-
J, Pu, N, Wang, Z-K, Huang, X-Y, He, and H-B, Yuan
- Subjects
Male ,Genotype ,Sufentanil ,Receptors, Opioid, mu ,Middle Aged ,Polymorphism, Single Nucleotide ,Laparoscopes ,Analgesics, Opioid ,Stomach Neoplasms ,Injections, Intravenous ,Intestinal Neoplasms ,Humans ,Female ,Oxycodone - Abstract
To explore the correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.Fifty-nine patients who underwent laparoscopic surgery for gastric or intestinal cancer under general anesthesia were included and randomly divided into oxycodone (n=30) and sufentanil groups (n=29) by reproducible random number generation method. Single nucleotide polymorphisms (SNPs) of four alleles: μ-opioid receptor gene OPRM1 A118G, cytochrome P450 (CPY450) enzyme system: CPY3A4*1G, CYP3A5*3, and CYP2D6*10 were detected by PCR-pyrosequencing. Patients in sufentanil group received intravenous sufentanil injection during anesthesia induction, intraoperative maintenance, and postoperative analgesia, while those in oxycodone group received oxycodone. Patients' postoperative VAS score, opioid use, and prevalence of adverse reactions were recorded.The genotype distribution of OPRM1 A118G, CYP3A4*1G, CYP3A5*3, and CYP2D6*10 in Chinese gastric cancer/intestinal cancer patients accorded with the Hardy-Weinberg law (p0.05). OPRM1 A118G polymorphism correlated with postoperative VAS score and medication dosage, in oxycodone group (p0.05), while it didn't with those of sufentanil group. The VAS scores in GG group were higher than that in AA group and AG group at T6-T9, (p0.05); the postoperative pain remedies times in GG group were more than that in the AA and AG groups (p=0.002). CYP3A4*1G polymorphism related to postoperative VAS score, medication dosage and prevalence of adverse reactions in sufentanil group (p0.05), while it didn't with those of oxycodone group (p0.05). The total intraoperative medication in AA group was less than that in GG and GA groups (p0.01), with a higher prevalence of respiratory depression (p=0.01). Nor was there any correlation of CYP3A5*3 and CYP2D6*10 polymorphisms with the efficacy, postoperative VAS score, pain remedies times, postoperative 24 h medication dosage, or prevalence of adverse reactions in oxycodone and sufentanil groups.Gene polymorphism affects the efficacy and adverse reactions of opioids in patients undergoing laparoscopic gastric or intestinal cancer surgery.
- Published
- 2019